Insights

AI cartilage imaging and the joint preservation decision

A 2026 retrospective study found that global cartilage quality metrics missed focal biochemical damage that 3D AI sector-wise mapping revealed at anatomical sites targeted by preservation surgery, directly reshaping counselling on whether preservation is biologically viable.

Professor Paul Y. F. Lee8 min read
AI cartilage imaging and the joint preservation decision

The clinical gap these tools are trying to close

Somewhere between a normal joint and one that unambiguously needs replacing sits a group of patients who are, in practice, among the hardest to counsel well. They are typically in their forties or early fifties: active, often still working physically, with pain that is real and cartilage damage that is visible — yet not so far advanced that total joint replacement is clearly the right answer. The question is not whether something is wrong. It is whether enough cartilage survives, and where, to make preservation biologically worthwhile and timed correctly.

Conventional weightbearing X-rays cannot answer that question reliably at this stage; joint space narrowing appears late, after meaningful structural loss has already occurred. Standard MRI reads help, but manual cartilage assessment is slow, reader-dependent, and difficult to reproduce across different radiologists or between follow-up appointments. In a busy NHS environment, where a patient may be seen by more than one surgeon and imaged at different time points, that inconsistency is not merely inconvenient — it can directly affect the advice given at the most consequential decision point in the patient's management.

Articular cartilage has no blood supply and no nerve supply of its own, and its capacity for intrinsic repair is limited; once structural loss is established, the preservation window narrows. The clinical need, then, is for objective, reproducible three-dimensional cartilage staging that can inform the timing and patient-selection judgement at the preservation–replacement threshold — before that window closes.

What nnU-Net and its newer variants actually do

Standard deep learning models for image segmentation typically need an expert to set dozens of training parameters — patch size, network depth, learning rate, data preprocessing — before they will work reliably on a new imaging task. nnU-Net removes that dependency: it inspects the imaging dataset it is given and configures its own architecture and training pipeline automatically. That self-configuring property is why it became the reference benchmark across more than 23 public medical image segmentation challenges, and why subsequent architectures — including the two discussed here — are built on top of it rather than from scratch.

nnAtrousU-Net and nnAtrousTransFormer extend the base framework by introducing atrous, or dilated, convolutions. A useful way to think about the difference: a standard convolution reads a small patch of an image at a time, like examining a single word in isolation. A dilated convolution spaces out its sampling points, reading across a wider field without discarding the intervening detail — closer to scanning a whole sentence while still registering each letter. For thin, curved articular cartilage — femoral cartilage is typically only 2–4 mm thick — that wider context matters, because the structure is easily missed or its edges blurred when the model only sees a narrow local window.

nnAtrousTransFormer takes this further by incorporating transformer self-attention blocks, which allow the model to reason about relationships across the whole joint simultaneously rather than patch by patch. It is worth noting, however, that adding more transformer blocks did not consistently improve segmentation accuracy in published testing: the two-block variant marginally outperformed the four-block version on both femoral and tibial cartilage metrics — a reminder that architectural complexity does not automatically translate into diagnostic value.

The practical output from either model is a voxel-level three-dimensional segmentation of cartilage surfaces — femoral and tibial, alongside bone — derived from a standard 3D MRI acquisition, with no manual contouring required.

How accurate these models are — and what the numbers mean

The numbers reported on the OAI-ZIB knee dataset give a reasonable starting point for calibrating expectations. DSC — Dice Similarity Coefficient — measures the overlap between a model's automated contour and a specialist's reference annotation: a DSC of 90% means that roughly nine in ten voxels are labelled identically by machine and expert. That leaves one in ten as a source of disagreement, typically concentrated at cartilage edges, lesion margins, and zones of partial volume — precisely where clinical decisions are most sensitive.

On femoral cartilage, nnAtrousU-Net reached a DSC of 90.46±2.86 and an average surface distance of 0.17±0.06 mm; nnAtrousTransFormer-2 achieved 90.08±2.63. Tibial cartilage was harder for both, with the transformer variant reaching 86.57±4.18. Bone segmentation was near-perfect at around DSC 98.76 in both femur and tibia — the more demanding problem is always cartilage, particularly in severe OA where osteophytes and bone-on-bone contact degrade peripheral accuracy. Adding more transformer depth did not resolve that: the four-block variant of nnAtrousTransFormer scored marginally below the two-block version across cartilage metrics, confirming that architectural complexity is not a reliable proxy for diagnostic precision.

Placed in the wider field, these figures are competitive at the time of publication, but the landscape is moving. SAMRI-2, a memory-based Vision Foundation Model reported in Nature Scientific Reports in 2025, achieved average DSC gains of approximately 0.05 over standard 3D nnU-Net — rising to 0.12 for tibial cartilage — though it requires interactive prompting of around three user clicks per volume. A 2024 benchmarking review further cautions that many architecture novelty claims over nnU-Net do not survive rigorous validation; well-scaled CNN-based U-Nets remain highly competitive. The honest position is that both models represent a credible and clinically meaningful step at the time of publication, not a settled endpoint.

From segmentation map to surgical decision — the clinical application

A 2026 Bone & Joint retrospective study of 55 hips, reviewed between 2020 and 2024, illustrates precisely what this class of imaging tool adds at the preservation decision. Using a validated nnU-Net pipeline, the researchers generated patient-specific 3D acetabular cartilage models — not a single global score, but a topographic map divided into clock-face sectors and central/peripheral zones, with sector-wise dGEMRIC values encoding local biochemical cartilage quality at each anatomical region.

The result that matters clinically: global dGEMRIC did not differ between protrusio and dysplastic hips (595±129 ms versus 576±89 ms; p=0.70). A conventional assessment relying on global metrics would have found no meaningful difference between groups. The 3D sectoral data told a different story — dysplastic hips showed focal biochemical vulnerability specifically at the anterior and posterior acetabular horns, with regional differences of 80–200 ms reaching statistical significance (p≤0.04). That damage was load-dependent rather than morphology-dependent, and it was concentrated in the zones most directly addressed — or missed — by periacetabular osteotomy, rim trimming, or early THA. Topographic specificity of that kind changes the information available when counselling a patient about what preservation can and cannot achieve in their particular hip.

Separately, nnU-Net-based radiomic models have demonstrated an AUC of 0.985 for predicting OA incidence at pre-radiographic stages — a research-phase finding, but one pointing toward a potential role for these pipelines in identifying patients who are approaching an intervention window before structural loss forecloses biological options.

The map narrows uncertainty and surfaces focal findings that global scores obscure. Closing that uncertainty — integrating imaging findings with a patient's age, functional demands, symptom trajectory, and bilateral joint status — remains the work of the clinician who has examined them.

What limits routine clinical use today

Every model reviewed here is research-grade. Training on the OAI-ZIB dataset — knee-specific, acquired under controlled conditions on defined hardware — means that performance across different scanner vendors, field strengths, or pulse sequences has not been systematically established. This phenomenon, called domain shift, is the principal barrier between a high-performing segmentation tool and routine NHS deployment: a model optimised for one acquisition protocol may produce meaningfully degraded outputs on the next, without alerting the clinician.

Accuracy also falls in precisely the cases where imaging guidance would be most clinically useful. Severe OA, with osteophyte formation and bone-on-bone contact, degrades automated cartilage delineation at peripheral joint regions — the zones where classification uncertainty is highest and where the preservation-versus-replacement decision is most contested.

A practical constraint for longitudinal monitoring: knee positioning during acquisition affects measured cartilage thickness, though not volume. Standardising positioning across multi-centre NHS protocols is a prerequisite for serial measurements to carry meaningful clinical weight.

The most important gap is the absence of prospective outcome data. No controlled study has demonstrated that using nnAtrousTransFormer or nnAtrousU-Net outputs directly improves patient selection, surgical timing, or clinical outcomes. Segmentation accuracy and clinical benefit are not the same evidence.

Research is actively addressing these barriers through domain adaptation, semi-supervised learning, and foundation model transfer. Interactive approaches — including SAMRI-2's click-based prompting, which requires as few as three user inputs per volume — represent a practical bridge toward deployable precision. Multi-centre validation trials are the necessary next step; routine clinical deployment is a plausible three-to-five-year horizon, conditional on that evidence emerging.

What this means for patients considering joint preservation

Patients told their joint is "not bad enough for replacement yet" but no longer managing on conservative treatment sit in exactly the uncertainty these tools were built to address. For those with localised damage, reasonable joint anatomy, and genuine ambiguity about preservation viability, 3D AI-assisted cartilage mapping can bring objective, reproducible detail to what is otherwise a judgement made on experience and conventional imaging alone.

What the scan provides is topographic specificity — where damage sits, how focal or diffuse it is, and whether biochemical change precedes visible structural loss in the zones that matter for a particular procedure. What it does not provide is a treatment plan. Timing, technique selection, and realistic outcome expectations remain the surgeon's judgement.

Access is currently concentrated in academic and specialist tertiary centres. Patients approaching a referral would be well served by asking whether 3D cartilage mapping forms part of the pre-operative assessment, which joint structures will be mapped, and what specific clinical question the imaging is being used to answer. The sector-wise vulnerability pattern identified in the 2026 acetabular dGEMRIC study — focal biochemical deficit at the anterior and posterior horns in dysplastic hips, invisible on global scoring — illustrates precisely the kind of question a scan-informed consultation can now begin to answer with geographic precision. Knowing where cartilage quality is failing, and in which zones, changes the conversation about what preservation might achieve and for whom.

  1. [1] nnU-Net: A self-configuring method for deep learning-based biomedical image segmentation. (2020). https://doi.org/10.1038/s41592-020-01008-z https://doi.org/10.1038/s41592-020-01008-z
  2. [2] AI-Powered 3D Cartilage Mapping in Protrusio Versus Dysplasia. (2026). https://doi.org/10.1302/1358-992x.2026.4.064 https://doi.org/10.1302/1358-992x.2026.4.064
  3. [3] nnU-Net Revisited: A Call for Rigorous Validation in 3D Medical Image Segmentation. (2024). https://doi.org/10.48550/arXiv.2404.09556 https://doi.org/10.48550/arXiv.2404.09556
  4. [4] A memory based model for cartilage and meniscus segmentation in 3D knee MRI. (2025). https://doi.org/10.1038/s41598-025-31503-2 https://doi.org/10.1038/s41598-025-31503-2
  5. [5] Knee Positioning Influences Cartilage Thickness but Not Volume in MRI Segmentation. (2025). https://doi.org/10.23919/MEASUREMENT66999.2025.11078648 https://doi.org/10.23919/MEASUREMENT66999.2025.11078648
  6. [6] Advancing deep learning based knee cartilage segmentation in MRI: Innovations, challenges and applications. (2025). https://doi.org/10.1016/j.ocarto.2025.100702 https://doi.org/10.1016/j.ocarto.2025.100702

Frequently Asked Questions

  • Patients aged in their forties or early fifties with documented cartilage damage insufficient for replacement, where timing and preservation viability are genuinely unclear. The imaging provides objective detail at this critical decision threshold that conventional imaging cannot reliably answer.
  • Dilated convolutions space out sampling points across a wider field without discarding intervening detail — critical for femoral cartilage only 2–4 mm thick. Standard convolutions examining narrow windows easily miss or blur cartilage edges; the wider context preserves subtle structural information.
  • Roughly nine in ten voxels match between automated and expert annotation. The one-in-ten disagreements concentrate at cartilage edges, lesion margins, and partial-volume zones — precisely where preservation-versus-replacement decisions are most sensitive and clinically consequential.
  • Domain shift is the principal barrier: models trained on one scanner vendor or acquisition protocol degrade on another without alerting clinicians. Accuracy also falls in severe osteoarthritis where guidance matters most. Prospective outcome data demonstrating improved patient selection is still lacking.
  • It identifies focal biochemical vulnerability invisible to global metrics. A 2026 study found dysplastic hips showed regional cartilage deficits at anterior and posterior horns with 80–200 ms dGEMRIC differences — topographic specificity that changes counselling about what preservation can achieve.

Preserve. Repair. Replace last.

If this describes your joint, it is worth a second opinion.

Consultations, imaging review and medico-legal instruction go through one place. Tell us what you need and Professor Lee's team will point you to the right route.

Privacy & Cookies Policy